Rare disease realities: Patient perspectives across the EU
References [1] Fabry Disease. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/16235-fabry-disease [2] Familial Hemophagocytic Lymphohistiocytosis. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK1444/ [3] Autosomal recessive congenital ichthyosis 4B. National Library of Medicine. https://www.ncbi.nlm.nih.gov/medgen/108615 [4] European Reference Networks. European Commission. https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/european-reference-networks_en [5] CRA Insights. A Landscape Assessment of Newborn Screening (NBS) in Europe. Charles River Associates. https://media.crai.com/wp-content/uploads/2021/11/28135510/CRA-Insights-NBS-Policy-Updated-28-February-2024-vSTCCR.pdf
References
[1] Fabry Disease. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/16235-fabry-disease
[2] Familial Hemophagocytic Lymphohistiocytosis. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK1444/
[3] Autosomal recessive congenital ichthyosis 4B. National Library of Medicine. https://www.ncbi.nlm.nih.gov/medgen/108615
[4] European Reference Networks. European Commission. https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/european-reference-networks_en
[5] CRA Insights. A Landscape Assessment of Newborn Screening (NBS) in Europe. Charles River Associates. https://media.crai.com/wp-content/uploads/2021/11/28135510/CRA-Insights-NBS-Policy-Updated-28-February-2024-vSTCCR.pdf
What's Your Reaction?
